Liver injury in acute fatty liver of pregnancy: Possible link to placental mitochondrial dysfunction and oxidative stress

Hepatology

Volumn 51, Issue 1, 2010, Pages 191-200

  Natarajan, Sathish Kumar ^a   Thangaraj, Kavitha R ^a   Eapen, C E ^a   Ramachandran, Anup ^a   Mukhopadhya, Ashis ^a   Mathai, Mathews ^a   Seshadri, Lakshmi ^a   Peedikayil, Abraham ^a   Ramakrishna, Banumathi ^a   Balasubramanian, Kunnissery A ^a,b  

^a CHRISTIAN MEDICAL COLLEGE   (India)

^b Meenakshi Medical College and Research Institute   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID;

ADULT; APOPTOSIS; ARTICLE; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY ACID ANALYSIS; FATTY LIVER; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID COMPOSITION; LIPID STORAGE; LIVER CELL CULTURE; LIVER MITOCHONDRION; NITROSATIVE STRESS; OXIDATIVE STRESS; PEROXISOME; PLACENTA DISORDER; PREGNANCY; PRIORITY JOURNAL;

ANTIOXIDANTS; FATTY LIVER; FEMALE; HUMANS; MITOCHONDRIA; OXIDATIVE STRESS; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS; REACTIVE OXYGEN SPECIES;

EID: 73449143826     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.23245     Document Type: Article

References (56)

1. Lee WS, Sokol RJ. Liver disease in mitochondrial disorders. Semin Liver Dis 2007;27:259-273.
2. Rolfes DB, Ishak KG. Acute fatty liver of pregnancy: a clinicopathologic study of 35 cases. HEPATOLOGY 1985;5:1149-1158.
3. Treem WR, Rinaldo P, Hale DE, Stanley CA, Millington DS, Hyams JS, et al. Acute fatty liver of pregnancy and long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. HEPATOLOGY 1994;19:339-345.
4. Shekhawat P, Bennett MJ, Sadovsky Y, Nelson DM, Rakheja D, Strauss AW. Human placenta metabolizes fatty acids: implications for fetal fatty acid oxidation disorders and maternal liver diseases. Am J Physiol Endocrinol Metab 2003;284:E1098-E1105.
5. Blish KR, Ibdah JA. Maternal heterozygosity for a mitochondrial trifunctional protein mutation as a cause for liver disease in pregnancy. Med Hypotheses 2005;64:96-100.
6. Browning MF, Levy HL, Wilkins-Haug LE, Larson C, Shih VE. Fetal fatty acid oxidation defects and maternal liver disease in pregnancy. Obstet Gynecol 2006;107:115-120.
7. Maitra A, Domiati-Saad R, Yost N, Cunningham G, Rogers BB, Bennett MJ. Absence of the G1528C (E474Q) mutation in the alpha-subunit of the mitochondrial trifunctional protein in women with acute fatty liver of pregnancy. Pediatr Res 2002;51:658-661.
8. Kong XF, Zhang XX, Yu YY, Shi Q, La DD, Zhu-Ge CD, et al. No mutation was found in the alpha-subunit of the mitochondrial tri-functional protein in one patient with severe acute fatty liver of pregnancy and her relatives. J Gastroenterol Hepatol 2007;22:2107-2111.
9. Reyes H, Sandoval L, Wainstein A, Ribalta J, Donoso S, Smok G, et al. Acute fatty liver of pregnancy: a clinical study of 12 episodes in 11 patients. Gut 1994;35:101-106.
10. Hay WW Jr. The placenta. Not just a conduit for maternal fuels. Diabetes 1991;40(Suppl. 2):44-50.
11. Rakheja D, Bennett MJ, Foster BM, Domiati-Saad R, Rogers BB. Evidence for fatty acid oxidation in human placenta, and the relationship of fatty acid oxidation enzyme activities with gestational age. Placenta 2002;23:447-450.
12. Xu Y, Wang Q, Cook TJ, Knipp GT. Effect of placental fatty acid metabolism and regulation by peroxisome proliferator activated receptor on pregnancy and fetal outcomes. J Pharm Sci 2007;96:2582-2606.
13. Ventura FV, Ruiter JP, Ijlst L, de Almeida IT, Wanders RJ. Inhibitory effect of 3-hydroxyacyl-CoAs and other long-chain fatty acid beta-oxidation intermediates on mitochondrial oxidative phosphorylation. J Inherit Metab Dis 1996;19:161-164.
14. Natarajan SK, Eapen CE, Pullimood AB, Balasubramanian KA. Oxidative stress in experimental liver microvesicular steatosis: role of mitochondria and peroxisomes. J Gastroenterol Hepatol 2006;21:1240-1249.
15. Mikhail MS, Anyaegbunam A, Garfinkel D, Palan PR, Basu J, Romney SL. Preeclampsia and antioxidant nutrients: decreased plasma levels of reduced ascorbic acid, alpha-tocopherol, and beta-carotene in women with preeclampsia. Am J Obstet Gynecol 1994;171:150-157.
16. Dani R, Mendes GS, Medeiros Jde L, Peret FJ, Nunes A. Study of the liver changes occurring in preeclampsia and their possible pathogenetic connection with acute fatty liver of pregnancy. Am J Gastroenterol 1996;91:292-294.
17. Wang Y, Walsh SW. Placental mitochondria as a source of oxidative stress in pre-eclampsia. Placenta 1998;19:581-586.
18. Mannaerts GP, Debeer LJ, Thomas J, De Schepper PJ. Mitochondrial and peroxisomal fatty acid oxidation in liver homogenates and isolated hepatocytes from control and clofibrate-treated rats. J Biol Chem 1979;254:4585-4595.
19. Treem WR. Beta oxidation defects: biochemistry and clinical. Clin Liver Dis 1999;3:49-67.
20. Ch'ng CL, Morgan M, Hainsworth I, Kingham JG. Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut 2002;51:876-880.
21. Martinez F, Kiriakidou M, Strauss JF 3rd. Structural and functional changes in mitochondria associated with trophoblast differentiation: methods to isolate enriched preparations of syncytiotrophoblast mitochondria. Endocrinology 1997;138:2172-2183.
22. Madesh M, Ramachandran A, Balasubramanian KA. Nitric oxide prevents anoxia-induced apoptosis in colonic HT29 cells. Arch Biochem Biophys 1999;366:240-248.
23. Takeyama N, Matsuo N, Tanaka T. Oxidative damage to mitochondria is mediated by the Ca(2+)-dependent inner-membrane permeability transition. Biochem J 1993;294(Pt. 3):719-725.
24. Madesh M, Bhaskar L, Balasubramanian KA. Enterocyte viability and mitochondrial function after graded intestinal ischemia and reperfusion in rats. Mol Cell Biochem 1997;167:81-87.
25. Scarpa A. Measurements of cation transport with metallochromic indicators. Methods Enzymol 1979;56:301-338.
26. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-358.
27. Sohal RS, Agarwal S, Dubey A, Orr WC. Protein oxidative damage is associated with life expectancy of houseflies. Proc Natl Acad Sci U S A 1993;90:7255-7259.
28. Habeeb AFSA. Reaction of protein sulfhydryl groups with Ellman's reagent. Methods Enzymol 1972;25:457.
29. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
30. Aebi H. Catalase in vitro. Methods Enzymol 1984;105:121-126.
31. Pennington RJ. Biochemistry of dystrophic muscle. Mitochondrial succinate-tetrazolium reductase and adenosine triphosphatase. Biochem J 1961;80:649-654.
32. Postaire E, Kouyate D, Rousset G, Regnault C, Lati E, Bejot M, et al. Plasma concentrations of beta-carotene, vitamin A and vitamin E after beta-carotene and vitamin E intake. Biomed Chromatogr 1993;7:136-138.
33. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37:911-917.
34. Cohen P, Derksen A. Comparison of phospholipid and fatty acid composition of human erythrocytes and platelets. Br J Haematol 1969;17:359-371.
35. Chang RS. Continuous subcultivation of epithelial-like cells from normal human tissues. Proc Soc Exp Biol Med 1954;87:440-443.
36. Hung WC, Chuang LY, Tsai JH, Chang CC. Effects of epidermal growth factor on growth control and signal transduction pathways in different human hepatoma cell lines. Biochem Mol Biol Int 1993;30:319-328.
37. Chen Q, Galleano M, Cederbaum AI. Cytotoxicity and apoptosis produced by arachidonic acid in Hep G2 cells overexpressing human cytochrome P4502E1. J Biol Chem 1997;272:14532-14541.
38. Wu D, Cederbaum AI. Role of p38 MAPK in CYP2E1-dependent arachidonic acid toxicity. J Biol Chem 2003;278:1115-1124.
39. Wang G, Gong Y, Anderson J, Sun D, Minuk G, Roberts MS, et al. Antioxidative function of L-FABP in L-FABP stably transfected Chang liver cells. HEPATOLOGY 2005;42:871-879.
40. Wu D, Cederbaum AI. Cyclosporine A protects against arachidonic acid toxicity in rat hepatocytes: role of CYP2E1 and mitochondria. HEPATOLOGY 2002;35:1420-1430.
41. Jou MJ, Jou SB, Chen HM, Lin CH, Peng TI. Critical role of mitochondrial reactive oxygen species formation in visible laser irradiation-induced apoptosis in rat brain astrocytes (RBA-1). J Biomed Sci 2002;9:507-516.
42. McMillian MK, Grant ER, Zhong Z, Parker JB, Li L, Zivin RA, et al. Nile Red binding to HepG2 cells: an improved assay for in vitro studies of hepatosteatosis. In Vitr Mol Toxicol 2001;14:177-190.
43. Hay JE. Liver disease in pregnancy. HEPATOLOGY 2008;47:1067-1076.
44. Eapen CE, Ramakrishna B, Jose R, Loganathan G, Chandy G. Liver failure during pregnancy. Gut 2008;57:83.
45. Wang Y, Walsh SW. Increased superoxide generation is associated with decreased superoxide dismutase activity and mRNA expression in placental trophoblast cells in pre-eclampsia. Placenta 2001;22:206-212.
46. Hashimoto T, Fujita T, Usuda N, Cook W, Qi C, Peters JM, et al. Peroxisomal and mitochondrial fatty acid beta-oxidation in mice nullizygous for both peroxisome proliferator-activated receptor alpha and peroxisomal fatty acyl-CoA oxidase. Genotype correlation with fatty liver phenotype. J Biol Chem 1999;274:19228-19236.
47. Tserng KY, Jin SJ, Kerr DS, Hoppel CL. Urinary 3-hydroxydicarboxylic acids in pathophysiology of metabolic disorders with dicarboxylic aciduria. Metabolism 1991;40:676-682.
48. Wang Y, Walsh SW. Antioxidant activities and mRNA expression of superoxide dismutase, catalase, and glutathione peroxidase in normal and preeclamptic placentas. J Soc Gynecol Investig 1996;3:179-184.
49. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996;271:C1424-C1437.
50. Chappell LC, Seed PT, Briley AL, Kelly FJ, Lee R, Hunt BJ, et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet 1999;354:810-816.
51. Eisele JW, Barker EA, Smuckler EA. Lipid content in the liver of fatty metamorphosis of pregnancy. Am J Pathol 1975;81:545-560.
52. Martins de Lima T, Cury-Boaventura MF, Giannocco G, Nunes MT, Curi R. Comparative toxicity of fatty acids on a macrophage cell line (J774). Clin Sci (Lond) 2006;111:307-317.
53. Cocco T, Di Paola M, Papa S, Lorusso M. Arachidonic acid interaction with the mitochondrial electron transport chain promotes reactive oxygen species generation. Free Radic Biol Med 1999;27:51-59.
54. Chen Q, Galleano M, Cederbaum AI. Cytotoxicity and apoptosis produced by arachidonic acid in HepG2 cells overexpressing human cytochrome P-4502E1. Alcohol Clin Exp Res 1998;22:782-784.
55. Brunt EM. Pathology of fatty liver disease. Mod Pathol 2007;20(Suppl. 1):S40-S48.
56. Fowler SD, Greenspan P. Application of Nile red, a fluorescent hydrophobic probe, for the detection of neutral lipid deposits in tissue sections: comparison with oil red O. J Histochem Cytochem 1985;33:833-836.